SCHEMBL11268847

SCHEMBL11268847

CC(=O)OCC1=C(C(=O)[O-])N2C(=O)[C@@H](NC(=O)C(O)c3ccccc3)[C@H]2SC1.[Na+]

nearest known ligand 0.70

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS1 known ✓ P23219 1/20 0.70
▸ PPARG known ✓ P37231 1/20 0.54
▸ TDP1 Q9NUW8 10/20 0.65
▸ MAPT P10636 10/20 0.65
▸ HSD17B10 Q99714 6/20 0.65
▸ CYP3A4 P08684 5/20 0.65
▸ KDM4E B2RXH2 5/20 0.65
▸ APEX1 P27695 3/20 0.65
▸ POLB P06746 3/20 0.65
▸ HPGD P15428 3/20 0.65
▸ BLM P54132 3/20 0.65
▸ LMNA P02545 3/20 0.65
▸ PTPN7 P35236 2/20 0.65
▸ MEN1 O00255 2/20 0.65
▸ KMT2A Q03164 2/20 0.65
▸ GLA P06280 1/20 0.65
▸ PKM P14618 1/20 0.65
▸ SMN1; SMN2 Q16637 1/20 0.65
▸ NPSR1 Q6W5P4 1/20 0.65
▸ ALDH1A1 P00352 2/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11444104 1.00 PTGS1 (0.70) PTGS1TDP1MAPTHSD17B10CYP3A4
SCHEMBL11393467 0.93 TDP1 (0.63) PTGS1TDP1MAPTHSD17B10CYP3A4
SCHEMBL11215612 0.92 PTGS1 (0.82) PTGS1TDP1MAPTHSD17B10CYP3A4
SCHEMBL8883027 0.92 PTGS1 (0.82) PTGS1TDP1MAPTHSD17B10CYP3A4
SCHEMBL11690164 0.89 PTGS1 (0.69) PTGS1TDP1MAPTHSD17B10CYP3A4
SCHEMBL11243991 0.88 TDP1 (0.62) PTGS1TDP1MAPTHSD17B10CYP3A4
SCHEMBL11879476 0.88 TDP1 (0.67) PTGS1TDP1MAPTHSD17B10CYP3A4
SCHEMBL11228661 0.87 TDP1 (0.67) PTGS1TDP1MAPTHSD17B10CYP3A4
SCHEMBL11856810 0.87 PTGS1 (0.64) PTGS1TDP1MAPTHSD17B10CYP3A4
SCHEMBL11698766 0.86 PTGS1 (0.61) PTGS1TDP1MAPTHSD17B10CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0000285-B1 7-ACYLAMINO-3-((3-(CARBOXYMETHYL) THIO-1 H-1,2,4-TRIAZOL-5-YL) THIOMETHYL)-3-CEPHEM-4-CARBOXYLIC ACID DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM SMITHKLINE BECKMAN CORPORATION (US) 1982-02-17 — — EP disclosed
US-4174324-A 3-(Carboxymethyl)thio-1H-1,2,4-triazol-5-thione SMITHKLINE CORPORATION (US) 1979-11-13 — — US disclosed
EP-0000285-A1 7-Acylamino-3-((3-(carboxymethyl) thio-1 H-1,2,4-triazol-5-yl) thiomethyl)-3-cephem-4-carboxylic acid derivatives, processes for their preparation and compositions containing them SMITHKLINE BECKMAN CORPORATION (US) 1979-01-10 — — EP disclosed
US-4117124-A ANTIBACTERIAL SMITHKLINE CORPORATION (US) 1978-09-26 — — US disclosed
US-4008227-A ANTIBIOTIC TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) 1977-02-15 — — US disclosed
Send feedback